MolNFT v1 · #93483 · protein
Crystal structure of CRISPR-associated protein CSE1 from acidimicrobium ferrooxidans
4H3T · CRISPR-associated protein, CSE1 family: “Crystal structure of CRISPR-associated protein CSE1 from acidimicrobium ferrooxidans”. X-ray diffraction, 4 pockets (best druggability 0.68). MolNFT v1 #93483 on GenesisL1: 3D structure…
- PDB
- 4H3T
- Type
- protein
- Length
- 517 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- CRISPR-associated protein, CSE1 family
- UniProt
- C7LYW9
- Pockets
- 4 · best druggability 0.68
Structure
x-ray diffraction · 1 distinct chain · 44% helix, 19% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | CRISPR-associated protein, CSE1 family | protein | 517 | 44% helix, 19% strand | C7LYW9 |
Ligands and binding sites
- GOL · Glycerol · additive · 2 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 66 | 0.68 | 0.95 | 25 | GOL |
| 2 | 59 | 0.59 | 0.91 | 19 | GOL |
| 3 | 138 | 0.50 | 0.79 | 28 | empty |
| 4 | 68 | 0.37 | 0.78 | 16 | empty |
Modifications
Observed in the structure: 5 modified (engineered).
Compared structures
- 4H3T · Crystal structure of CRISPR-associated protein Cse1 from Acidimicrobium ferrooxidans · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt C7LYW9
- Elsewhere: RCSB PDB 4H3T · PDBe 4H3T · UniProt C7LYW9
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.